SPRY2 deficiency leads to CRPC

Slides:

Advertisements

Similar presentations

Effects of inhibiting inflammatory cell recruitment on fracture healing Treatment with CCR2 antagonist, INCB3344, led to impaired fracture healing compared.

Advertisements

Impact of triple combination of gemcitabine‐based chemoirradiation with anti‐PD‐L1 in the KPC tumor allograft Impact of triple combination of gemcitabine‐based.

Morphology of white adipose tissue and muscle in S1/3 KO mice of different ages Morphology of white adipose tissue and muscle in S1/3 KO mice of different.

Loss of Hdac3 impairs Ar signaling in mouse prostate tissues and has no effect on apoptosis Loss of Hdac3 impairs Ar signaling in mouse prostate tissues.

TZD enhances cisplatin sensitivity through suppression of endotrophin‐mediated EMT, fibrosis and angiogenesis.A,B.Schematic diagram for allografts (A),

The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth The HDAC3 inhibitor suppresses SPOP‐mutated prostate cancer cell growth A22Rv1.

PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection PbA‐specific CD4 T‐cell responses are maximal at day 6 post‐pRBC infection Proportion.

SPRY2 deficiency leads to CRPC

The absence of COL6 in PyMT mice sensitizes tumours to cisplatin treatment.A.Eleven week old FP635/PyMT and FP635/PyMT/COL6−/− mice were given cisplatin.

Roles of systemic versus tumour SK1 in the regulation of local tumour growth and lung colonization/metastasis.A.Effects of siRNA‐mediated SK1 knockdown.

SPRY2 deficiency mediates androgen autonomous CRPC

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.

Metabolic profile of Tfe3 KO mice

SPRY2 deficiency mediates androgen autonomous CRPC

ECM29 mediates palbociclib‐induced proteasomal activation and may function as a putative biomarker for palbociclib treatment efficacy in breast cancer.

Tumour‐induced IL6 increases systemic cholesterol levels

Expression of FUT9 supports tumor development

Stat3 promotes lung fibrosis and collagen synthesis independent of Smad3.A.Masson's trichrome stained sections of lung from gp130wt (wt), Smad3−/− (Smad3−/−),

TFE3 prevents diet‐induced obesity and metabolic syndrome

SPP1 and TNC are induced by active JNK and promote lung metastasis

JNK signaling mediates mammary tumor growth and metastasis to lungs

EGFL7 affected tumor growth and reduced overall survival

Histological analysis of tumours in PyMT mice with different levels of endotrophin after chemotherapy.A.Endotrophin staining and quantification, showing.

Expression and occupancy of a set of transcription factors corresponding to the identified motifs at FAIRE peaks Expression and occupancy of a set of transcription.

PEX13 is required for Sindbis virophagy but not general autophagy

SPRY2 deficiency mediates CRPC

Loss of Ifnar1 signaling elicits inflammatory processes and angiogenesis in laser‐induced retinal damage Loss of Ifnar1 signaling elicits inflammatory.

SOM230 increases in vivo sensitivity to gemcitabine of tumour xenograft (MIA PaCa‐2‐Luc cells and CAFs or human PDAC resection) A–CMIA PaCa‐2‐GLuc cells.

Combined BET/MEK inhibition offsets therapy resistance

IFN‐β ameliorates microgliosis and inhibits choroidal neovascularization IFN‐β ameliorates microgliosis and inhibits choroidal neovascularization AExperimental.

SPRY2 deficiency‐induced IL6 drives CRPC by elevating tumoral HSD3B1 and cholesterol levels SPRY2 deficiency‐induced IL6 drives CRPC by elevating tumoral.

Mitochondrial ceramide is involved in HPV‐E7‐mediated lethal mitophagy

Combination of OTX‐015 and PD does not induce overt toxicity

SPRY2 deficiency‐induced SRB1 mediates CRPC

Neutralizing endotrophin activity with monoclonal antibodies sensitizes tumours to cisplatin treatment.A.Pieces of tumours from PyMT mice were implanted.

BETi potentiate the efficacy of MEKi in NRAS‐mutant melanoma

Inhibition of JNK signaling sensitizes mammary tumors and metastases to chemotherapy Inhibition of JNK signaling sensitizes mammary tumors and metastases.

Molecular and morphological analysis of Pitrm1+/− mouse brain

Hdac3 deletion decreases AKT phosphorylation and tumor growth in Pten knockout prostate cancer Hdac3 deletion decreases AKT phosphorylation and tumor growth.

Rescuing mGPDH deficiency improves skeletal muscle regeneration during obesity and diabetes Rescuing mGPDH deficiency improves skeletal muscle regeneration.

Impaired ECM protein synthesis in infarcted area of S100a4cre+/− × Fstl1flox/flox mice Impaired ECM protein synthesis in infarcted area of S100a4cre+/−

Anti‐EGFL7 treatment for the treatment of glioma in vivo

The ER is the main source of cholesterol accumulated by STARD3 in endosomes The ER is the main source of cholesterol accumulated by STARD3 in endosomes.

Association of AIM2, RIG‐I and NLRP3 inflammasomes with better survival in NPC patients.A.Overexpression of ASC, caspase‐1 and IL‐1β proteins as well as.

Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+ tumors Effects of in vivo Nutlin‐3 treatment on CSC content of Numb− and Numb+

VAP silencing restores a normal plasma membrane cholesterol level in STARD3‐expressing cells VAP silencing restores a normal plasma membrane cholesterol.

Normal priming and expansion of functional T cells in the spleen during concurrent co‐infection Normal priming and expansion of functional T cells in the.

IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice IL‐23‐induced psoriasis‐like skin disease is ameliorated in IL‐23−/− mice ARepresentative.

Inhibition of NAMPT using the potent inhibitor FK866 sensitizes additional tumour cells to olaparib.A‐E.Sensitivity of the cell lines MDAMB468 (A), SUM149.

STARD3‐mediated cholesterol accumulation in endosomes occurs at the expense of plasma membrane STARD3‐mediated cholesterol accumulation in endosomes occurs.

EnAd‐EpCAMBiTE shows reproducible activity within an expanded cohort of patient malignant peritoneal and pleural exudates EnAd‐EpCAMBiTE shows reproducible.

In vivo efficacy of Olaparib in PTEN deficient xenografts.

BRD4 is associated with poor patient survival and constitutes a promising target for NRASMut melanoma BRD4 is associated with poor patient survival and.

Assessment of proliferation status of PDGFRα+ cells in developing mouse lungs Assessment of proliferation status of PDGFRα+ cells in developing mouse lungs.

The HDAC3 inhibitor suppresses PTEN‐deficient prostate cancer growth

MiR‐34a‐5p functionally contributes to arrested lung alveolarization in response to hyperoxia miR‐34a‐5p functionally contributes to arrested lung alveolarization.

IL6 stimulates hepatic cholesterol synthesis and SRB1 expression in CRPC IL6 stimulates hepatic cholesterol synthesis and SRB1 expression in CRPC ARelative.

Both the number and the OX40L expression level of bronchiolar progenitors were increased by influenza infection. Wild‐type mice were intratracheally infected.

Therapeutic role of TR in HFD‐established diabetic mice

PKAN human neurons show altered oxidative status

Tissue‐specific differences in the levels of CoQ9, CoQ10, and DMQ9, and in the DMQ9/CoQ9 ratio after β‐RA treatment in Coq9R239X mice Tissue‐specific differences.

SPRY2 deficiency‐induced IL6 drives CRPC by elevating tumoral HSD3B1 and cholesterol levels SPRY2 deficiency‐induced IL6 drives CRPC by elevating tumoral.

Sox2 is essential for SLG regeneration following radiation injury

GM1 decreases neuropathology and weight loss in R6/2 mice

Mpdz was localized proximal to the apical surface of CPECs

SPRY2 deficiency leads to CRPC

SPRY2 deficiency mediates CRPC

SEMA3C regulates prostate cancer cell growth

KLF4 is a key determinant in the development and progression of cerebral cavernous malformations qRT–PCR analysis of Klf4 during disease progression at.

Presentation transcript:

SPRY2 deficiency leads to CRPC SPRY2 deficiency leads to CRPC AKaplan–Meier plot for the relapse‐free survival of prostate cancer patients treated with androgen deprivation therapy (ADT). SPRY2‐high patients, n = 14; SPRY2‐low patients, n = 13; log‐rank (Mantel–Cox) test; P = 0.0189.BKaplan–Meier plot for overall (post‐diagnosis) survival of ADT‐treated prostate cancer patients. SPRY2‐high patients, n = 12; SPRY2‐low patients, n = 7; log‐rank (Mantel–Cox) test; P = 0.0306.CRepresentative images for immunostaining for SPRY2 in HN (hormone‐naïve) and CRPC (castration‐resistant prostate cancer) matched clinical prostate cancer sections. Scale bars = 100 μm.DImmunostaining for SPRY2 in HN and CRPC matched clinical prostate cancer sections represented as IHC (immunohistochemistry) scores (n = 35 pairs; paired two‐tailed Student's t‐test; *P = 0.0009).ERepresentative H&E and immunostained images of prostate sections from Nkx3.1 Ptenfl/+Spry2fl/+ (NPS) mice. Scale bars = 100 μm.FProstate tumour burden 1 month post‐ADT in NPS mice (n = 6 mice per group; unpaired two‐tailed Student's t‐test; *P = 0.0009).GProstate tumour burden at clinical endpoint in NPS mice (n = 5 mice per group).H, IGrowth rate of LNCaP control and SPRY2‐overexpressing cells (H); and CWR22Res Nsi (non‐silencing) control and CL3 and Pool stable SPRY2 knockdown cell lines (I) relative to T0 (Day 0) in hormone‐proficient (FBS) medium and hormone‐depleted (CSS) medium (n = 3; *P < 0.05; ANOVA Tukey's test).JCWR22Res prostate orthograft tumour volumes from 60‐days timed experiment (n = 5 mice per group; *P < 0.05; ANOVA Tukey's test).KThe effects of ADT on the CWR‐22 prostate orthografts from 60‐days timed experiment represented as % necrosis/tumour weight (n = 5 mice per group; *P < 0.05; ANOVA Tukey's test).Data Information: In (D, F, G, J, K), each data point represents one independent observation. In (H, I), each data point is mean of three independent observations. In (D, F, G–K), data are presented as mean ± SD. Rachana Patel et al. EMBO Mol Med. 2018;10:e8347 © as stated in the article, figure or figure legend